Validation of PDGFRbeta and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib (Q40084316)
Jump to navigation
Jump to search
scientific article published on 4 June 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Validation of PDGFRbeta and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib |
scientific article published on 4 June 2008 |
Statements
1 reference
Validation of PDGFRbeta and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib (English)
1 reference
Carlo Gambacorti-Passerini
0 references
Domenico Ribatti
1 reference
Pierfrancesco Tassone
1 reference
Addolorata Maria Luce Coluccia
1 reference
Teresa Cirulli
1 reference
Paola Neri
1 reference
Maria Cristina Colanardi
1 reference
Antonio Gnoni
1 reference
Nicola Di Renzo
1 reference
Franco Dammacco
1 reference
Angelo Vacca
1 reference
4 June 2008
1 reference
Identifiers
1 reference